Related Experiment Videos
[Long-term effects of partial splenic embolization (PSE) for hypersplenism]
Rinsho Hoshasen. Clinical Radiography
|August 1, 1989
Summary
Splenic artery embolization (SAE) using Gelfoam particles effectively treated hypersplenism. Higher embolization rates correlated with longer improvements in white blood cell and platelet counts, with some patients remaining well for over two years.
Area of Science:
- Interventional Radiology
- Hematology
Background:
- Hypersplenism presents a clinical challenge, often requiring interventions to manage cytopenias.
- Splenic artery embolization (SAE) is a potential therapeutic option for hypersplenism.
Purpose of the Study:
- To evaluate the efficacy and safety of SAE using Gelfoam particles for treating hypersplenism.
Main Methods:
- Twenty-four patients with hypersplenism underwent SAE with Gelfoam particles.
- Embolization levels were assessed, and hematological parameters (WBC and platelet counts) were monitored post-procedure.
Main Results:
- Significant improvements in white blood cell (WBC) and platelet counts were observed.
- Cases with over 60% embolization showed sustained hematological improvement for approximately 19-20 months.
- Nine patients with >60% embolization remained in good condition for over two years, with two patients exceeding three years.
Conclusions:
- SAE with Gelfoam particles is an effective treatment for hypersplenism, offering durable hematological improvements.
- Higher embolization rates are associated with longer-lasting benefits.
- While generally safe, potential complications like splenic abscess require careful consideration.